DK0600396T3 - Vacciner mod tarmprotozoer - Google Patents

Vacciner mod tarmprotozoer

Info

Publication number
DK0600396T3
DK0600396T3 DK93119126T DK93119126T DK0600396T3 DK 0600396 T3 DK0600396 T3 DK 0600396T3 DK 93119126 T DK93119126 T DK 93119126T DK 93119126 T DK93119126 T DK 93119126T DK 0600396 T3 DK0600396 T3 DK 0600396T3
Authority
DK
Denmark
Prior art keywords
methods
vaccines against
against intestinal
intestinal protozoa
vaccines
Prior art date
Application number
DK93119126T
Other languages
English (en)
Inventor
Merle E Olson
Howard Ceri
Douglas W Morck
Original Assignee
Univ Technologies Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Technologies Int filed Critical Univ Technologies Int
Application granted granted Critical
Publication of DK0600396T3 publication Critical patent/DK0600396T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK93119126T 1992-12-04 1993-11-26 Vacciner mod tarmprotozoer DK0600396T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98548992A 1992-12-04 1992-12-04
US08/156,618 US5512288A (en) 1992-12-04 1993-11-23 Giardia vaccine

Publications (1)

Publication Number Publication Date
DK0600396T3 true DK0600396T3 (da) 2002-10-28

Family

ID=26853351

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93119126T DK0600396T3 (da) 1992-12-04 1993-11-26 Vacciner mod tarmprotozoer

Country Status (9)

Country Link
US (3) US5512288A (da)
EP (1) EP0600396B1 (da)
JP (2) JP3856345B2 (da)
AT (1) ATE220557T1 (da)
CA (1) CA2109977C (da)
DE (1) DE69332111T2 (da)
DK (1) DK0600396T3 (da)
ES (1) ES2177535T3 (da)
PT (1) PT600396E (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549899A (en) * 1992-12-04 1996-08-27 University Technologies International, Inc. Giardia vaccine
GB9403819D0 (en) * 1994-02-28 1994-04-20 Univ Leeds Control of parasites
GB9417880D0 (en) * 1994-09-06 1994-10-26 Auspharm Int Ltd Vaccine
AUPN353695A0 (en) * 1995-06-14 1995-07-06 Commonwealth Scientific And Industrial Research Organisation Immunogenic preparation and method for improving the productivity of ruminant animals
WO1997029120A1 (en) * 1996-02-05 1997-08-14 Sarco Research Corporation Limited Sarcocystine isolation
US20030235903A1 (en) * 2002-06-20 2003-12-25 University Technologies International, Inc. Propagation of cryptosporidium in cell culture
CA2557481A1 (en) * 2004-02-26 2005-09-09 Murdoch University Culture methods for cryptosporidium
AT502702B1 (de) * 2005-05-12 2008-05-15 Veterinaermedizinische Uni Wie Verfahren zur herstellung und anwendung von protozoenkulturen
MX351579B (es) * 2008-12-02 2017-10-20 Univ Catolica De Cordoba Protozoario modificado que expresa al menos dos proteinas de superficie variables (vsp), una vacuna que lo comprende y procedimiento, y usos y metodos de la misma.
KR101631312B1 (ko) * 2014-06-16 2016-06-20 연세대학교 산학협력단 재조합 람블편모충 결합 면역글로블린 단백질을 포함하는 면역증강 조성물
US10716850B2 (en) 2014-12-31 2020-07-21 Wellin, Inc. Anti-inflammatory factor retentate, method of isolation, and use
US10478493B2 (en) 2015-08-31 2019-11-19 Stolle Milk Biologics, Inc. Method of treating protozoal gastrointestinal disorders in immunocompromised patients

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639280A5 (de) * 1977-12-23 1983-11-15 Solco Basel Ag Verfahren zur herstellung einer vakzine gegen das trichomonas-syndrom.
US4314992A (en) * 1978-11-08 1982-02-09 Bitakaramire Peter K Process for producing fascioliasis vaccine
IL59663A (en) * 1980-03-19 1983-02-23 Univ Ramot Vaccines obtained from bacterial mutant strains of enterobacteriaceae and pseudomonaceae
US5077044A (en) * 1980-05-19 1991-12-31 The Board Of Trustees Of The Leland Stanford Jr. University Novel non-reverting shigella live vaccines
EP0071705B1 (en) * 1981-05-21 1989-11-23 The Wellcome Foundation Limited Protozoal antigen
US4493825A (en) * 1982-10-05 1985-01-15 Iowa State University Research Foundation Purified and antigenically selective vaccines for domestic animals
US4639372A (en) * 1984-06-29 1987-01-27 Merck & Co., Inc. Coccidiosis vaccine
US4687666A (en) * 1985-02-19 1987-08-18 Ministerio De Sanidad Y Asistencia Social Instituto Venezolano De Investigationes Cientificas Vaccine for Leishmaniasis
US4724145A (en) * 1985-11-18 1988-02-09 Merck & Co., Inc. Eimeria acervulina immunogens
US5028694A (en) * 1985-12-03 1991-07-02 Solvay & Cie, S.A. Antigenic proteins and vaccines containing them for prevention of coccidiosis caused by eimeria Eimeria necatrix and Eimeria tenella
US5106618A (en) * 1987-07-02 1992-04-21 Stolle Research And Development Corporation Method of treating protozoal gastrointestinal disorders by administering hyperimmune milk product
US4808404A (en) * 1988-01-11 1989-02-28 A. H. Robins Company, Inc. Live vaccine for coccidiosis utilizing coccidial sporozoites
US5045313A (en) * 1989-07-07 1991-09-03 The University Of Kansas Vaccine for immunizing cats against toxoplasma oocyst shedding

Also Published As

Publication number Publication date
CA2109977C (en) 2009-05-12
ES2177535T3 (es) 2002-12-16
EP0600396A2 (en) 1994-06-08
PT600396E (pt) 2002-12-31
US5922329A (en) 1999-07-13
US6153191A (en) 2000-11-28
DE69332111T2 (de) 2003-02-27
EP0600396A3 (en) 1995-07-12
US5512288A (en) 1996-04-30
JP2004137286A (ja) 2004-05-13
DE69332111D1 (de) 2002-08-22
ATE220557T1 (de) 2002-08-15
JPH0789872A (ja) 1995-04-04
CA2109977A1 (en) 1994-06-05
JP3856345B2 (ja) 2006-12-13
EP0600396B1 (en) 2002-07-17

Similar Documents

Publication Publication Date Title
NO983999D0 (no) Peptidimmunogener for vaksinasjon mot og behandling av allergi
MY131388A (en) Inhibitors of hiv protease useful for the treatment of aids.
RU93048636A (ru) 7-/замещенные/-8-/замещенные/-9-/замещенные амино/-6-диметил-6-дезокситетрациклины, промежуточные соединения, способы получения соединений, способ профилактики и лечения и фармацевтическая композиция
FR12C0004I1 (da)
DK0600396T3 (da) Vacciner mod tarmprotozoer
HU901585D0 (en) Method for treatment of viral infections using functional derivatives of icam-1
NL300403I1 (en) Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe
YU174491A (sh) Vakcine
DE69732709D1 (de) Expressionsblockierung von virulenten faktoren in s. aureus
IL105119A0 (en) Immunoglobins and antigens for the treatment of staphylococcus infections,methods for the identification and preparation thereof and pharmaceutical compositions containing the same
DE69631381T2 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
DE69429856D1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
ATE283920T1 (de) Verfahren zur immunisierung und behandlung von h. pylori infektion
DK0684842T3 (da) Præparat til behandling af tumorer og immunisering af organismer over for tumorer
NO933628D0 (no) Fremgangsmaate og blanding for behandling av herpes-infeksjoner
MX9400210A (es) Tratamiento de infecciones virales.